MEI Pharma Inc (MEIP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11455 EL CAMINO REAL SAN DIEGO, CA 92130

Develops and commercializes drugs for the treatment of cancer. Focuses on a drug candidate called phenoxodiol, which it believes may have broad application against a range of cancers. The development stage company (as of September 2005) is a subsidiary of Novogen Limited, an Australian company.

Data as of 2021-05-08 10:41:31 -0400
Market Cap372.679 Million Shares Outstanding112.592 Million Avg 30-day Volume587.691 Thousand
P/E Ratio-10.25223 Dividend Yield EPS-0.329
Price/Sales9.38 Debt to Equity2.77 EBITDA-34.403 Million
Price to Book Value5.07 Forward PE-6.76 Enterprise Value192.535 Million
Total Cash180.144 Million Current Debt37.012 Million Gross Profit37.404 Million
BETA0.82538 52-week High/Low4.58 / 2.29 Next Earnings Date Price to Cash FLow (P/CF) -33.7069
Data provided by IEX Cloud
View SEC Filings from MEIP instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 2 (0.12%) 2 (0.12%) 0.0%
Funds Holding: 110 105 4.76% 35 (2.1%) 35 (2.18%) 0.0%
13F shares: 75.569 Million 76.225 Million -0.86% 36.001 Million 37.75 Million -4.63%
% Ownership 67.1589 67.7426 -0.86% 31.9944 33.5491 -4.63%
New Positions: 15 18 -16.67% 4 9 -55.56%
Increased Positions 49 30 63.33% 16 11 45.45%
Closed Positions 10 17 -41.18% 4 9 -55.56%
Reduced Positions 24 37 -35.14% 11 12 -8.33%
Total Calls 1.188 Million 629.187 Thousand 88.81% 25.7 Thousand 65.9 Thousand -61.0%
Total Puts 92.605 Thousand 101.556 Thousand -8.81% 0 21.6 Thousand -100.0%
PUT/CALL Ratio 0.08 0.16 -50.0% 0.0 0.33 -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MEIP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MEIP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GHALIE RICHARD G CHIEF MEDICAL OFFICER

  • Officer
2,080,000 2021-05-03 2

DRISCOLL FREDERICK W

  • Director
37,500 2021-02-23 2

GOLD DANIEL P PHD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
453,632 2020-07-23 2

BALTIC CHARLES V. III

  • Director
0 2020-07-02 1

WHITE CHRISTINE ANNA

  • Director
0 2020-07-02 1

MASS ROBERT D. CHIEF MEDICAL OFFICER

  • Officer
0 2020-07-02 1

REYNOLDS THOMAS C

  • Director
0 2020-07-02 1

GLOVER NICHOLAS

  • Director
0 2020-07-02 1

URSO DAVID M CHIEF OPERATING OFFICER & GC

  • Officer
74,106 2020-07-02 1

CLEMENS KEVAN

  • Director
0 2020-07-02 1

DRAZBA BRIAN G. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-07-02 1

HOWSON TAMAR D

  • Director
0 2020-07-02 1

COHEN CHERYL

  • Director
0 2020-07-02 1

RUECKERT WILLIAM DODGE

  • Director
0 2019-07-01 0

ZECH THOMAS M. CHIEF FINANCIAL OFFICER

  • Officer
0 2016-08-05 0

CANN LEAH RUSH

  • Director
0 2016-07-29 0

VIVO VENTURES V, LLC

  • 10% Owner
No longer subject to file 2015-11-05 0

VIVO VENTURES VII, LLC

  • 10% Owner
No longer subject to file 2015-11-05 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

RATCLIFFE LIAM

  • 10% Owner
No longer subject to file 2015-03-24 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

RATCLIFFE LIAM

  • 10% Owner
1,680,475 2013-11-21 0

VIVO VENTURES V, LLC

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

  • 10% Owner
180,015 2013-10-25 0

VIVO VENTURES VII, LLC

VIVO VENTURES FUND VII, L.P.

VIVO VENTURES VII AFFILIATES FUND, L.P.

  • 10% Owner
3,098,503 2013-10-25 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

  • 10% Owner
2,045,475 2013-05-06 0

NEW LEAF VENTURES II, L.P.

NEW LEAF VENTURE ASSOCIATES II, L.P.

NEW LEAF VENTURE MANAGEMENT II, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

HUNT RONALD

LATHI VIJAY K

DELAGARDELLE JEANI

AKKARAJU SRINIVAS

  • 10% Owner
2,502,775 2013-02-15 0

AUSTIN JOSIAH T

  • 10% Owner
0 2012-12-06 0

NOVOGEN LTD

  • 10% Owner
No longer subject to file 2012-12-03 0

AUSTIN JOSIAH T

EL CORONADO HOLDINGS, LLC

  • 10% Owner
3,832,081 2012-12-03 0

WILLIAMS BRYAN

  • Director
0 2012-09-21 0

JOHNSTON PHILIP A

  • Director
10,000 2009-05-18 0

SEATON DAVID R CFO & SECRETARY

  • Officer
5,000 2008-03-13 0

NAUGHTON CHRISTOPHER CEO & PRESIDENT

  • Officer
  • Director
5,000 2008-02-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GHALIE RICHARD G - Officer CHIEF MEDICAL OFFICER

2021-05-05 16:02:02 -0400 2021-05-03 A 75,000 a 75,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MEI PHARMA INC MEIP 2021-05-10 22:15:04 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 21:45:02 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 21:15:02 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 20:45:03 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 20:15:03 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 19:45:03 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 19:15:03 UTC -0.7594 0.8094 850000
MEI PHARMA INC MEIP 2021-05-10 18:45:03 UTC -0.81 0.86 850000
MEI PHARMA INC MEIP 2021-05-10 18:15:03 UTC -0.81 0.86 850000
MEI PHARMA INC MEIP 2021-05-10 17:45:02 UTC -0.81 0.86 850000
MEI PHARMA INC MEIP 2021-05-10 17:15:03 UTC -0.81 0.86 850000
MEI PHARMA INC MEIP 2021-05-10 16:45:03 UTC -0.81 0.86 850000
MEI PHARMA INC MEIP 2021-05-10 16:15:03 UTC -0.81 0.86 850000
MEI PHARMA INC MEIP 2021-05-10 15:45:03 UTC -0.81 0.86 650000
MEI PHARMA INC MEIP 2021-05-10 15:15:03 UTC -0.81 0.86 650000
MEI PHARMA INC MEIP 2021-05-10 14:45:04 UTC -0.5313 0.5813 650000
MEI PHARMA INC MEIP 2021-05-10 14:15:04 UTC -0.5313 0.5813 650000
MEI PHARMA INC MEIP 2021-05-10 13:45:04 UTC -0.5313 0.5813 650000
MEI PHARMA INC MEIP 2021-05-10 13:15:03 UTC -0.5313 0.5813 650000
MEI PHARMA INC MEIP 2021-05-10 12:45:02 UTC -0.5313 0.5813 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments